ABBOTT LABORATORIES — Director's Dealing 2011

Feb 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-02-18

Reporting Person: Hance Robert B (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-18	Common shares without par value	A	25300	—	Acquired	140698	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-18	Option (right to buy)	$46.60	A	35600	Acquired	2021-02-17	Common shares (35600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	6426	Indirect
Common shares without par value	20000	Indirect
Common shares without par value	150	Indirect
Common shares without par value	150	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2011.

F3: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,867 on 02/18/2012, 11,866 on 02/18/2013, and 11,867 on 02/18/2014.